Medicine and Dentistry
Streptococcus Pneumoniae
100%
Patient
71%
Therapeutic Procedure
38%
Child
33%
Antiinfective Agent
27%
Community-Acquired Pneumonia
26%
Blood Vessel Graft
26%
Culture
21%
Antibiotics
21%
Adult
21%
Personnel
20%
Hospital
18%
Retrospective Study
17%
Mortality
15%
Pathogen
14%
Nursing Home
13%
Aspiration
13%
Breast Cancer
13%
Tumor Progression
13%
Membrane Vesicle
13%
Acute Otitis Media
13%
Neutrophil
13%
Retrospective Cohort Study
13%
Conservative Treatment
13%
Age
12%
Symptom
10%
Antimicrobial Therapy
10%
Follow up
7%
Morbidity
6%
Cohort Effect
6%
Resident
6%
Antibiotic Therapy
6%
Combination Therapy
6%
RNA 18S
5%
Immunology and Microbiology
Serotype
60%
Pneumococcal Vaccine
43%
Infectious Agent
34%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
26%
Haemophilus influenzae
24%
Bacterium
24%
Growth
18%
Bronchoalveolar Lavage Fluid
16%
Penicillin
14%
Titer
13%
Lineages
13%
Virus
13%
Otitis Media
13%
Pneumococcus
13%
Spectrum
13%
Innate Immune System
13%
Antigen
9%
Mouse
9%
Monospecific Antibody
7%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
6%
Pilus
6%
Polymerase Chain Reaction
5%
Immunity
5%
Adaptive Immune System
5%
Pharmacology, Toxicology and Pharmaceutical Science
Respiratory Tract
39%
Streptococcus Pneumoniae
26%
Community Acquired Pneumonia
26%
Infection
26%
Ventilator Associated Pneumonia
18%
Antibiotics
14%
Pneumonia
14%
Staphylococcal Bacteremia
13%
Multiple Drug Resistance
13%
Incidence
13%
Prospective Study
13%
Case-Control Study
13%
Amoxicillin
13%
Clindamycin
9%
Erythromycin
8%
Penicillin G
8%
Minimum Inhibitory Concentration
8%
Antibiotic Therapy
7%
4 Aminobutyric Acid
6%
Antimicrobial Resistance
6%
Penicillin Derivative
6%
Pneumococcus Vaccine
6%
Retrospective Study
5%